Nortilidine: Difference between revisions

Nortilidine
Identifiers
	IUPAC name ethyl (1R,2S)-2-(methylamino)-1-phenylcyclohex-3-ene-1-carboxylate;
CAS Number	38677-94-0;
ChEMBL	ChEMBL1614654;
CompTox Dashboard (EPA)	DTXSID10191256 ;
Chemical and physical data
Formula	H21NO2
Molar mass	259.3434 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCOC([C@@]1(C2=CC=CC=C2)CCC=C[C@@H]1NC)=O;
	InChI InChI=InChI=1S/C16H21NO2/c1-3-19-15(18)16(13-9-5-4-6-10-13)12-8-7-11-14(16)17-2/h4-7,9-11,14,17H,3,8,12H2,1-2H3/t14-,16+/m1/s1; Key:InChIKey=PDJZPNKVLDWEKI-ZBFHGGJFSA-N;

Browse history interactively

← Previous edit Next edit →

Content deleted Content added

VisualWikitext

Inline

Revision as of 16:32, 7 October 2012

Nortilidine^[1] is the active metabolite of the drug tilidine. It is formed from tilidine by demethylation in the liver. The racemate has opioid analgesic effects roughly equivalent in potency to that of morphine^[2] but virtually all of the opioid activity resides in the (1R,2S) isomer^[3]. The (1S,2R) isomer has NMDA antagonist activity. The drug also acts as a dopamine reuptake inhibitor.

References

^ US Patent 3792080 - Process for Substituted Cyclohexenes & it's Products
^ J Clin Pharmacol. 2002 Nov ;42 (11):1257-61 - Sequential first-pass metabolism of nortilidine: the active metabolite of the synthetic opioid drug tilidine
^ Opiates: George R. Lenz page 439, Table 9-30 (78)

[1] US Patent 3792080 - Process for Substituted Cyclohexenes & it's Products

[2] J Clin Pharmacol. 2002 Nov ;42 (11):1257-61 - Sequential first-pass metabolism of nortilidine: the active metabolite of the synthetic opioid drug tilidine

[3] Opiates: George R. Lenz page 439, Table 9-30 (78)

[1]

[2]

[3]

@@ Line 66: / Line 66: @@
 }}
-'''Nortilidine'''<ref>US Patent 3792080 - Process for Substituted Cyclohexenes & it's Products</ref> is the [[active metabolite]] of the drug [[tilidine]]. It is formed from tilidine by [[demethylation]] in the [[liver]]. The racemate has opioid analgesic effects roughly equivalent in potency to that of morphine<ref>J Clin Pharmacol. 2002 Nov ;42 (11):1257-61 - Sequential first-pass metabolism of nortilidine: the active metabolite of the synthetic opioid drug tilidine</ref> but virtually all of the opioid activity resides in the (1R,2S) isomer<ref>Opiates: George R. Lenz page 439</ref>. The (1S,2R) isomer has [[NMDA antagonist]] activity. The drug also acts as a [[dopamine reuptake inhibitor]].
+'''Nortilidine'''<ref>US Patent 3792080 - Process for Substituted Cyclohexenes & it's Products</ref> is the [[active metabolite]] of the drug [[tilidine]]. It is formed from tilidine by [[demethylation]] in the [[liver]]. The racemate has opioid analgesic effects roughly equivalent in potency to that of morphine<ref>J Clin Pharmacol. 2002 Nov ;42 (11):1257-61 - Sequential first-pass metabolism of nortilidine: the active metabolite of the synthetic opioid drug tilidine</ref> but virtually all of the opioid activity resides in the (1R,2S) isomer<ref>Opiates: George R. Lenz page 439, Table 9-30 (78)</ref>. The (1S,2R) isomer has [[NMDA antagonist]] activity. The drug also acts as a [[dopamine reuptake inhibitor]].
 ==See also==